Pharmaceutical Exports

Mankind Pharma Acquires Roche’s Rivotril Brand to Strengthen CNS Portfolio in India

21 Mar, 2026 11 mins read 44 views

In a strategic move, Mankind Pharma has acquired the rights of Roche’s Rivotril brand in India. The deal strengthens its presence in CNS therapies and is expected to improve availability and affordability of clonazepam for patients with epilepsy and related conditions.

Medical News

Gland Pharma’s ₹6.29 Crore GST Dispute: What Investors Need to Know Introduction

10 Mar, 2026 13 mins read 80 views

Explore Gland Pharma’s ₹6.29 crore GST dispute from Telangana authorities over export reclassifications and credit notes for FY 2019-20. The company deems it unjustified and plans an appeal, assuring no major impact. Dive into company overview, market reactions, stock performance, and broader pharma sector implications as of March 9, 2026. Solid fundamentals persist amid short-term volatility.